Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | MGLL | Q99685 | 1/20 | 0.46 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 4/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | STAT1 | P42224 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | F2 | P00734 | 1/20 | 0.42 |
| ▸ | ELANE | P08246 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL133554 | 0.93 | KMT2A (0.53) | KMT2AALDH1A1MGLLLMNATSHR | |
| SCHEMBL19309377 | 0.93 | KMT2A (0.53) | KMT2AALDH1A1MGLLLMNATSHR | |
| SCHEMBL15169078 | 0.90 | KMT2A (0.48) | KMT2AMGLLLMNATSHRNPC1 | |
| SCHEMBL15169077 | 0.90 | KMT2A (0.48) | KMT2AMGLLLMNATSHRNPC1 | |
| SCHEMBL13588629 | 0.90 | KMT2A (0.43) | KMT2AALDH1A1MGLLSRD5A2LMNA | |
| SCHEMBL300884 | 0.88 | CA12 (0.42) | KMT2AALDH1A1MGLLLMNAMAPT | |
| SCHEMBL4872950 | 0.87 | SMN1; SMN2 (0.54) | KMT2AMGLLNPC1MAPTHPGD | |
| SCHEMBL27717830 | 0.84 | CA1 (0.55) | KMT2AALDH1A1MGLLSRD5A2TSHR | |
| SCHEMBL6705699 | 0.84 | NAAA (0.50) | KMT2AALDH1A1SRD5A2SMN1; SMN2MEN1 | |
| SCHEMBL5136264 | 0.84 | AKR1C3 (0.49) | KMT2AALDH1A1MGLLL3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 253 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115677922-B | Dual-functional polymer and modification method | 深圳市曙芯生物科技有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-115677922-A | Difunctional polymer and modification method | 深圳市曙芯生物科技有限公司 | 2023-02-03 | — | — | CN | claimed |
| CN-111565707-A | Devices and methods for delivering therapeutics | 森玛治疗公司 | 2020-08-21 | — | — | CN | claimed |
| EP-3638205-A1 | DEVICES AND METHODS FOR DELIVERING THERAPEUTICS | Semma Therapeutics, Inc. (US) | 2020-04-22 | — | — | EP | claimed |
| WO-2018232180-A1 | DEVICES AND METHODS FOR DELIVERING THERAPEUTICS | SEMMA THERAPEUTICS, INC. (US) | 2018-12-20 | — | — | WO | claimed |
| EP-2478049-B1 | A POLYMER SUPPORT | UNIV CAPE TOWN (ZA) | 2015-02-25 | — | — | EP | claimed |
| EP-2333548-B1 | Biological indicator | AMERICAN STERILIZER CO (US) | 2014-07-30 | — | — | EP | claimed |
| US-8420802-B2 | Polymer support | UNIVERSITY OF CAPE TOWN (ZA) | 2013-04-16 | — | — | US | claimed |
| EP-2478049-A1 | A POLYMER SUPPORT | University of Cape Town (ZA) | 2012-07-25 | — | — | EP | claimed |
| US-20120178916-A1 | Polymer Support | UNIVERSITY OF CAPE TOWN (ZA) | 2012-07-12 | — | — | US | claimed |
| US-8128688-B2 | Carbon coating on an implantable device | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2012-03-06 | — | — | US | claimed |
| WO-2011083360-A1 | A POLYMER SUPPORT | UNIVERSITY OF CAPE TOWN (ZA) | 2011-07-14 | — | — | WO | claimed |
| WO-2008002632-A2 | CARBON COATING ON AN IMPLANTABLE DEVICE | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2008-01-03 | — | — | WO | claimed |
| US-20070298354-A1 | Carbon coating on an implantable device | ABBOTT CARDIOVASCULAR SYSTEMS INC. | 2007-12-27 | — | — | US | claimed |
| EP-4115806-B1 | ANALYTE SENSOR AND METHOD FOR MANUFACTURING AN ANALYTE SENSOR | ROCHE DIABETES CARE GMBH (DE) | 2026-05-20 | — | — | EP | disclosed |
| CN-122038263-A | Expansion method of single cell, single cell nucleus or single subcellular structure and application thereof | 浙江大学医学院附属第一医院(浙江省第一医院) | 2026-05-15 | — | — | CN | disclosed |
| US-12607591-B2 | Flux-limiting polymer membrane | ROCHE DIABETES CARE, INC. (US) | 2026-04-21 | — | — | US | disclosed |
| US-5718915-A | DRUG DELIVERY | BURSTEIN LABORATORIES, INC. (US) | 1998-02-17 | — | — | US | disclosed |
| WO-1996032841-A9 | NOVEL THERAPEUTIC BINDING MOLECULE COMPLEXES | — | 1996-12-27 | — | — | WO | disclosed |
| WO-1996032841-A1 | NOVEL THERAPEUTIC BINDING MOLECULE COMPLEXES | BURSTEIN LABORATORIES, INC. (US) | 1996-10-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12607591-B2 | Flux-limiting polymer membrane | SELP, EPCAM, SELPLG | KMT2A 4658/4885ALDH1A1 1834/4885MGLL 1356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.